182 related articles for article (PubMed ID: 16442285)
1. Benzoxazole benzenesulfonamides are novel allosteric inhibitors of fructose-1,6-bisphosphatase with a distinct binding mode.
von Geldern TW; Lai C; Gum RJ; Daly M; Sun C; Fry EH; Abad-Zapatero C
Bioorg Med Chem Lett; 2006 Apr; 16(7):1811-5. PubMed ID: 16442285
[TBL] [Abstract][Full Text] [Related]
2. Benzoxazole benzenesulfonamides as allosteric inhibitors of fructose-1,6-bisphosphatase.
Lai C; Gum RJ; Daly M; Fry EH; Hutchins C; Abad-Zapatero C; von Geldern TW
Bioorg Med Chem Lett; 2006 Apr; 16(7):1807-10. PubMed ID: 16446092
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of 7-nitro-1H-indole-2-carboxylic acid derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.
Bie J; Liu S; Zhou J; Xu B; Shen Z
Bioorg Med Chem; 2014 Mar; 22(6):1850-62. PubMed ID: 24530031
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel indole derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.
Bie J; Liu S; Li Z; Mu Y; Xu B; Shen Z
Eur J Med Chem; 2015 Jan; 90():394-405. PubMed ID: 25461330
[TBL] [Abstract][Full Text] [Related]
5. Orally active aminopyridines as inhibitors of tetrameric fructose-1,6-bisphosphatase.
Hebeisen P; Haap W; Kuhn B; Mohr P; Wessel HP; Zutter U; Kirchner S; Ruf A; Benz J; Joseph C; Alvarez-Sánchez R; Gubler M; Schott B; Benardeau A; Tozzo E; Kitas E
Bioorg Med Chem Lett; 2011 Jun; 21(11):3237-42. PubMed ID: 21550236
[TBL] [Abstract][Full Text] [Related]
6. Structure-guided design of AMP mimics that inhibit fructose-1,6-bisphosphatase with high affinity and specificity.
Erion MD; Dang Q; Reddy MR; Kasibhatla SR; Huang J; Lipscomb WN; van Poelje PD
J Am Chem Soc; 2007 Dec; 129(50):15480-90. PubMed ID: 18041833
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, SAR, and X-ray structure of tricyclic compounds as potent FBPase inhibitors.
Tsukada T; Takahashi M; Takemoto T; Kanno O; Yamane T; Kawamura S; Nishi T
Bioorg Med Chem Lett; 2009 Oct; 19(20):5909-12. PubMed ID: 19762234
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the allosteric binding pocket of human liver fructose-1,6-bisphosphatase by protein crystallography and inhibitor activity studies.
Iversen LF; Brzozowski M; Hastrup S; Hubbard R; Kastrup JS; Larsen IK; Naerum L; Nørskov-Lauridsen L; Rasmussen PB; Thim L; Wiberg FC; Lundgren K
Protein Sci; 1997 May; 6(5):971-82. PubMed ID: 9144768
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
Dang Q; Kasibhatla SR; Reddy KR; Jiang T; Reddy MR; Potter SC; Fujitaki JM; van Poelje PD; Huang J; Lipscomb WN; Erion MD
J Am Chem Soc; 2007 Dec; 129(50):15491-502. PubMed ID: 18041834
[TBL] [Abstract][Full Text] [Related]
10. [Recent advance in the discovery of allosteric inhibitors binding to the AMP site of fructose-1,6-bisphosphatase].
Li ZM; Bie JB; Song HR; Xu BL
Yao Xue Xue Bao; 2011 Nov; 46(11):1291-300. PubMed ID: 22260018
[TBL] [Abstract][Full Text] [Related]
11. Protein-based alignment in 3D-QSAR of FBPase inhibitors.
Yi P; Di YT; Liu W; Hao XJ; Ming Y; Huang DS; Yang J; Yi ZZ; Li ZJ; Yang RD; Zhang JC
Eur J Med Chem; 2011 Mar; 46(3):885-92. PubMed ID: 21269737
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationship of non-phosphorus-based fructose-1,6-bisphosphatase inhibitors: 2,5-Diphenyl-1,3,4-oxadiazoles.
Liao BR; He HB; Yang LL; Gao LX; Chang L; Tang J; Li JY; Li J; Yang F
Eur J Med Chem; 2014 Aug; 83():15-25. PubMed ID: 24946215
[TBL] [Abstract][Full Text] [Related]
13. Discovery of
Zhou J; Bie J; Wang X; Liu Q; Li R; Chen H; Hu J; Cao H; Ji W; Li Y; Liu S; Shen Z; Xu B
J Med Chem; 2020 Sep; 63(18):10307-10329. PubMed ID: 32820629
[TBL] [Abstract][Full Text] [Related]
14. Interaction between muscle aldolase and muscle fructose 1,6-bisphosphatase results in the substrate channeling.
Rakus D; Pasek M; Krotkiewski H; Dzugaj A
Biochemistry; 2004 Nov; 43(47):14948-57. PubMed ID: 15554702
[TBL] [Abstract][Full Text] [Related]
15. 3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP site.
Wright SW; Carlo AA; Danley DE; Hageman DL; Karam GA; Mansour MN; McClure LD; Pandit J; Schulte GK; Treadway JL; Wang IK; Bauer PH
Bioorg Med Chem Lett; 2003 Jun; 13(12):2055-8. PubMed ID: 12781194
[TBL] [Abstract][Full Text] [Related]
16. Determination of protein-ligand binding constants of a cooperatively regulated tetrameric enzyme using electrospray mass spectrometry.
Cubrilovic D; Haap W; Barylyuk K; Ruf A; Badertscher M; Gubler M; Tetaz T; Joseph C; Benz J; Zenobi R
ACS Chem Biol; 2014 Jan; 9(1):218-26. PubMed ID: 24128068
[TBL] [Abstract][Full Text] [Related]
17. Design of new benzoxazole-2-thione-derived inhibitors of Streptococcus pneumoniae hyaluronan lyase: structure of a complex with a 2-phenylindole.
Rigden DJ; Botzki A; Nukui M; Mewbourne RB; Lamani E; Braun S; von Angerer E; Bernhardt G; Dove S; Buschauer A; Jedrzejas MJ
Glycobiology; 2006 Aug; 16(8):757-65. PubMed ID: 16638841
[TBL] [Abstract][Full Text] [Related]
18. Kinetics and mechanisms of activation and inhibition of porcine liver fructose-1,6-bisphosphatase by monovalent cations.
Zhang R; Villeret V; Lipscomb WN; Fromm HJ
Biochemistry; 1996 Mar; 35(9):3038-43. PubMed ID: 8608143
[TBL] [Abstract][Full Text] [Related]
19. Relative binding affinities of fructose-1,6-bisphosphatase inhibitors calculated using a quantum mechanics-based free energy perturbation method.
Reddy MR; Erion MD
J Am Chem Soc; 2007 Aug; 129(30):9296-7. PubMed ID: 17616196
[No Abstract] [Full Text] [Related]
20. Ligand-based designing, in silico screening, and biological evaluation of new potent fructose-1,6-bisphosphatase (FBPase) inhibitors.
Tayyem RF; Zalloum HM; Elmaghrabi MR; Yousef AM; Mubarak MS
Eur J Med Chem; 2012 Oct; 56():70-95. PubMed ID: 22960695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
